Vimarsana
Biggest News Aggregation in the World

Page 47 - Lymph Nodes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lymph Nodes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lymph Nodes Today - Breaking & Trending Today

New research changes the paradigm of how people think about graft-versus-host disease - Vimarsana News

New research changes the paradigm of how people think about graft-versus-host disease

New research challenges the prevailing hypothesis for how donor stem cell grafts cause graft-versus-host disease, or GVHD, and offers an alternative model that could guide development of novel therapies.

Simple method increases the efficacy of T cell therapy by cytokine conjugation - Vimarsana News

Simple method increases the efficacy of T cell therapy by cytokine conjugation

The recent years have seen a wave of adoptive cell therapies (ACTs), a type of immunotherapy in which T cells (T cell transfer therapy) and other immune cells are obtained from patients, activated and multiplied outside the body, and infused in larger numbers back into the blood circulation to help fight cancers.

Could Nodal RT Explain Failure of ICIs in Head and Neck Cancer? - Vimarsana News

Could Nodal RT Explain Failure of ICIs in Head and Neck Cancer?

Immune checkpoint inhibitors (ICIs) have shown impressive efficacy in many different cancer types, but not in head and neck cancer: could nodal irradiation blunt the immune response?

COVID-19 vaccine potency and breadth improved by nanoparticle-conjugated adjuvants - Vimarsana News

COVID-19 vaccine potency and breadth improved by nanoparticle-conjugated adjuvants

In a recent study posted to bioRxiv*, researchers designed a nanoparticle (NP)-conjugated toll-like receptor 9 (TLR9) agonist to improve the adjuvanticity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines.

PSMA PET/MRI can successfully determine the risk of prostate cancer recurrence - Vimarsana News

PSMA PET/MRI can successfully determine the risk of prostate cancer recurrence

In men recently diagnosed with intermediate or high-grade prostate cancer, prostate specific membrane antigen (PSMA) PET/MRI can successfully determine whether their cancer is likely to return within two years of a prostatectomy.